Top Markets
Coin of the day
Abpro Corporation Abpro Corporation

Abpro Corporation

ABP
Clasificación en acciones #39900
Abpro Holdings, Inc. is a biotechnology firm dedicated to creating... Abpro Holdings, Inc. is a biotechnology firm dedicated to creating antibody-based treatments for patients suffering from conditions in immuno-oncology, ophthalmology, and autoimmunity. A key element of their strategy is the proprietary DiversImmune platform, which aims to resolve a significant hurdle in the antibody therapeutics sector. Their primary investigational drug candidates include ABP-100, designed to target breast, gastric, and colorectal cancers, and ABP-201, intended for the treatment of vascular diseases affecting the eye. The company has established strategic alliances with Abpro Bio Co. Ltd and NJCTTQ. Originally known as Abpro Corporation, the company officially changed its name to Abpro Holdings, Inc. in November 2024. Incorporated in 2004, Abpro Holdings, Inc. operates from its headquarters in Woburn, Massachusetts.
Precio por acción
$0.158
Última sincronización: 2026-04-06
Capitalización bursátil
$302.92K
Cambio (1 día)
16.18%
Cambio (1 año)
-97.91%
País
US
Comercio Abpro Corporation (ABP)

Categoría

Historial del precio de la acción de Abpro Corporation (ABP)
Precio más alto de cierre: $0.15 el 2026-04-01

Precio más bajo de cierre: $111.21 el 2024-11-01
Historial del precio de la acción de Abpro Corporation desde 2024 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -20.12%
2025 -91.12%
2024 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$517.18 32.51%
US
$857.76 31.47%
NL
$744.96 9.07%
CH
$1.07K -6.27%
KR
$259.89 14.81%
BE